PORTELLA MOLL, MARIA JESUS IR
mportella@santpau.cat
Abad Garcia, Sergi FGS
Alemany Santamaria, Carlo FGS
Almenta Gallego, David FGS
Alvarado Carrera, Pedro Jose FGS
Avila Parcet, Aina FGS
Batlle Batlle, Francesca FGS
Bauza Ramis, Joana Maria FGS
Cano Catala, Marta IR
Carceller Sindreu, Maria del Mar FGS
Cardoner Alvarez, Narcis FGS
Carmona Farres, Cristina FGS
Carrasco Hernandez, Julia IR
Casellas Pujol, Elisabet FGS
Catalan Martinez, Anna FGS
Corripio Collado, Iluminada IR
Costa Juste, Silvia Maria FGS
De Diego Adeliño, Francisco Javier FGS
De la Peña Arteaga, Victor IR
Diaz Perez, Anna Maria FGS
Dinamarca Caceres, Fernando Nicolas FGS
Espeso Gonzalez, Rocio FGS
Farre Martinez, Adriana FGS
Faustino Bosch, Gloria IR
Gawron, Leonor Patricia FGS
Grasa Bello, Eva Maria CIBERSAM
Isern Tena, Clara FGS
Jaramillo Muñumer, Maria CIBERSAM
Jubero Urgell, Miriam IR
Lopez Castro, Maria FGS
Madre Rull, Merce FGS
Martin Blanco, Ana FGS
Perez Blanco, Josefina FGS
Pousa Tomas, Esther FGS
Puigdemont Campos, Maria Dolors FGS
Remis Rebollo, Sergio FGS
Ribalta Corona, Elisa FGS
Roca Tutusaus, Francisco Javier Juan FGS
Roldan Bejarano, Alejandra FGS
Serrano Gimeno, Victor FGS
Soler Ribaudi, Joaquin FGS
Tiana Sastre, Thais FGS
Tome Perez, Jose Alberto FGS
Trujols Albet, Joan FGS
Vera Igual, Javier FGS
Vicent Gil, Muriel FGS
(JIF 2022)
-Aibar JA, Collado IC, Bejarano AR, Nevado RS, Bolanos IA, Garcia J, Alonso A, Bello E, Schmidt CD, Hernandez FM, Teixido JM, Rodriguez RR. Long-term outcomes of deep brain stimulation for treatment-resistant schizophrenia: Exploring potential targets. JOURNAL OF PSYCHIATRIC RESEARCH. 2023; 163DOI:10.1016/j.jpsychires.2023.05.056. PMID:37245316. IF:4,800 (Q2/3D).Document type: Article.
-Alcantarilla L, López M, Betriu M, Torres A, Garcia C, Solé E, Gelabert E, Roca A. Risk factors for relapse or recurrence in women with bipolar disorder and recurrent major depressive disorder in the perinatal period: a systematic review. Archives of Womens Mental Health. 2023; 26(6)DOI:10.1007/s00737-023-01370-9. PMID:37718376. IF:4,500 (Q2/4D).Document type: Review.
-Alemany C, Puigdemont D, Martín A, Rodríguez R, Aibar JA, Vicent M, Álvarez E, Pérez V, Portella MJ, de Diego J. Response and Safety Outcomes in Treatment-Resistant Depression After Subcallosal Cingulate Gyrus Deep Brain Stimulation: Long-term Follow-up Study. JOURNAL OF CLINICAL PSYCHIATRY. 2023; 84(4):22m14622. DOI:10.4088/JCP.22M14622. PMID:37378475. IF:5,300 (Q1/2D).Document type: Article.
-Arca G, Nunez C, Stephan C, Arnaez J, Agut T, Cordeiro M, Boronat N, Lubian S, Benavente I, Valverde E, Garcia A. Massive Neonatal Arterial Ischemic Stroke. PEDIATRIC NEUROLOGY. 2023; 144DOI:10.1016/j.pediatrneurol.2023.03.013. PMID:37087915. IF:3,800 (Q1/2D).Document type: Article.
-Argyelan M, Deng ZD, Ousdal OT, Oltedal L, Angulo B, Baradits M, Spitzberg AJ, Kessler U, Sartorius A, Dols A, Narr KL, Espinoza R, van JA, Tendolkar I, van P, van GA, Takamiya A, Kishimoto T, Jorgensen MB, Jorgensen A, Paulson OB, Yrondi A, Péran P, Soriano C, Cardoner N, Cano M, van L, Schrijvers D, Belge JB, Emsell L, Bouckaert F, Vandenbulcke M, Kiebs M, Hurlemann R, Mulders PCR, Redlich R, Dannlowski U, Erhan K, Kritzer MD, Ellard KK, Camprodon JA, Petrides G, Malhotra AK, Abbott CC. Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression. MOLECULAR PSYCHIATRY. 2023; DOI:10.1038/s41380-023-02318-2. PMID:37985787. IF:11,000 (Q1/1D).Document type: Article.
-Baeza I, de la Serna E, Mezquida G, Cuesta MJ, Vieta E, Amoretti S, Lobo A, Gonzalez A, Diaz CM, Corripio I, Valli I, Puig O, Mane A, Bioque M, Ayora M, Bernardo M, Castro J, PEPs GRP. Prodromal symptoms and the duration of untreated psychosis in first episode of psychosis patients: what differences are there between early vs. adult onset and between schizophrenia vs. bipolar disorder?. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2023; DOI:10.1007/s00787-023-02196-7. PMID:37027026. IF:6,400 (Q1/1D).Document type: Article.
-Blanken MAJT, Oudega ML, Hoogendoorn AW, Sonnenberg CS, Rhebergen D, Klumpers UMH, Van L, Birkenhager T, Schrijvers D, Redlich R, Dannlowski U, Heindel W, Coenjaerts M, Nordanskog P, Oltedal L, Kessler U, Frid LM, Takamiya A, Kishimoto T, Jorgensen MB, Jorgensen A, Bolwig T, Emsell L, Sienaert P, Bouckaert F, Abbott CC, Péran P, Arbus C, Yrondi A, Kiebs M, Philipsen A, van JA, Prinsen E, van M, Van G, ten F, Camprodon JA, Kritzer M, Barbour T, Argyelan M, Cardoner N, Urretavizcaya M, Soriano C, Narr KL, Espinoza RT, Prudic J, Rowny S, van P, Tendolkar I, Dols A. Sex-specifics of ECT outcome. JOURNAL OF AFFECTIVE DISORDERS. 2023; 326DOI:10.1016/j.jad.2022.12.144. PMID:36632848. IF:6,600 (Q1/2D).Document type: Article.
-Butjosa A, Usall J, Vila R, Mezquida G, Cuesta MJ, Rodriguez E, Amoretti S, Lobo A, Gonzalez A, Espliego A, Corripio I, Vieta E, Baeza I, Berge D, Bernardo M. Impact of traumatic life events on clinical variables of individuals with first-episode psychosis and healthy controls. INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY. 2023; 69(1):00207640211070398. DOI:10.1177/00207640211070398. PMID:35068217. IF:7,500 (Q1/2D).Document type: Article.
-Cano M, Camprodon JA. Understanding the Mechanisms of Action of Electroconvulsive Therapy Revisiting Neuroinflammatory and Neuroplasticity Hypotheses. JAMA Psychiatry. 2023; 80(6)DOI:10.1001/jamapsychiatry.2023.0728. PMID:37074712. IF:25,800 (Q1/1D).Document type: Editorial Material.
-Cano M, Lee E, Polanco C, Barbour T, Ellard KK, Andreou B, Uribe S, Henry ME, Seiner S, Cardoner N, Soriano C, Camprodon JA. Brain volumetric correlates of electroconvulsive therapy versus transcranial magnetic stimulation for treatment-resistant depression. JOURNAL OF AFFECTIVE DISORDERS. 2023; 333DOI:10.1016/j.jad.2023.03.093. PMID:37024015. IF:6,600 (Q1/2D).Document type: Article.
-Contreras O, Reales M, Fernandez S, Cimpean A, Arnoriaga M, Puig J, Biarnes C, Motger A, Cano M, Fernandez JM. Consumption of ultra-processed foods is associated with depression, mesocorticolimbic volume, and inflammation. JOURNAL OF AFFECTIVE DISORDERS. 2023; 335DOI:10.1016/j.jad.2023.05.009. PMID:37207947. IF:6,600 (Q1/2D).Document type: Article.
-Costas A, Verdolini N, Garcia C, Mezquida G, Janssen J, Valli I, Corripio I, Sanchez AM, Bioque M, Lobo A, Gonzalez A, Rapado M, Vieta E, de la Serna H, Mane A, Roldan A, Crossley N, Penades R, Cuesta MJ, Parellada M, Bernardo M, PEPs GRP. Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis. PSYCHOLOGICAL MEDICINE. 2023; DOI:10.1017/S0033291723003185. PMID:38014924. IF:6,900 (Q1/1D).Document type: Article.
-de la Serna E, Montejo L, Solé B, Castro-Fornieles J, Camprodon-Boadas P, Sugranyes G, Rosa-Justicia M, Martinez-Aran A, Vieta E, Vicent-Gil M, Serra-Blasco M, Cardoner N, Torrent C. Effectiveness of enhancing cognitive reserve in children, adolescents and young adults at genetic risk for psychosis: Study protocol for a randomized controlled trial. Span J Psychiatry Ment Health. 2023;16(3):184-191. DOI: 10.1016/j.rpsm.2021.02.003. PMID: 33631372. Document type: Article.
-De la Serna E, Puig O, Mezquida G, Moreno L, Merchan J, Amoretti S, Ruiz P, Gonzalez A, Molina M, Corripio I, Vieta E, Baeza I, Berge D, Penades R, Sanchez A, Cuesta MJ, Bernardo M, Castro J. Relationship between cognition and age at onset of first-episode psychosis: comparative study between adolescents, young adults, and adults. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2023; 32(4)DOI:10.1007/s00787-021-01901-8. PMID:34714406. IF:6,400 (Q1/1D).Document type: Article.
-Fagiolini A, Cardoner N, Pirildar S, Ittsakul P, Ng B, Duailibi K, El Hindy N. Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder. EXPERT OPINION ON PHARMACOTHERAPY. 2023; 24(15)DOI:10.1080/14656566.2023.2242264. PMID:37501324. IF:3,200 (Q3/6D).Document type: Review.
-Florido A, Velasco ER, Monari S, Cano M, Cardoner N, Sandi C, Andero R, Perez L. Glucocorticoid-based pharmacotherapies preventing PTSD. NEUROPHARMACOLOGY. 2023; 224:109344. DOI:10.1016/j.neuropharm.2022.109344. PMID:36402246. IF:4,700 (Q1/3D).Document type: Article.
-Fortea L, Tortella-Feliu M, Juaneda-Seguí A, De la Peña-Arteaga V, Chavarría-Elizondo P, Prat-Torres L, Soriano-Mas C, Lane SP, Radua J, Fullana MA. Development and Validation of a Smartphone-Based App for the Longitudinal Assessment of Anxiety in Daily Life. Assessment. 2023 Jun;30(4):959-968. doi: 10.1177/10731911211065166. Epub 2021 Dec 30. PMID: 34969314; PMCID: PMC9301625.IF:3,800 (Q2/3D).Document type: Article.
-Fraguas D, Almenta D, Arques S, Gómez M, Sánchez CG, Hernández D, Núñez D, Oda Plasencia B, Parro C, Romero SL, Ros E, Alamo C. Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 2023; 27(1)DOI:10.1080/13651501.2022.2064308. PMID:35792729. IF:3,000 (Q3/7D).Document type: Review.
-García J, Hijar R, López Y, Magallón R, Fernández S, Barceló A, Soler J, Montero J. Effectiveness of four deconstructive meditative practices on well-being and self-deconstruction: study protocol for an exploratory randomized controlled trial. Trials. 2023; 24(1):125. DOI:10.1186/s13063-023-07151-0. PMID:36805694. IF:2,500 (Q3/8D).Document type: Article.
-Goodman JM, Cuesta D, Alupoaei C, Bello E, Herrera J, Mayoral F, Guzman J. Psychometric validation of the 15-item Questionnaire about the Process of Recovery in Spain (QPR-15-SP). Frontiers in Psychology. 2023; 14:1178341. DOI:10.3389/fpsyg.2023.1178341. PMID:37484089. IF:3,800 (Q1/3D).Document type: Article.
-Gracia R, Portella MJ, Puntí J, Pujals E, Torralbas J, Llorens M, Pamias M, Fradera M, Montalvo I, Palao DJ. COVID-19 Pandemic Has Changed the Psychiatric Profile of Adolescents Attempting Suicide: A Cross-Sectional Comparison. International Journal of Environmental Research and Public Health. 2023; 20(4):2952. DOI:10.3390/ijerph20042952. PMID:36833651. IF:4,614 (Q1/3D).Document type: Article.
-Grasa E, Corripio I, Peris O, Roldán A, Selma J, Osma J. Opening Treatment Windows for Treatment-Resistant Schizophrenia: Improving Emotion Regulation Strategies Using the Unified Protocol in a Case Study in Spain. Clinical Case Studies. 2023; DOI:10.1177/15346501231190912. IF:1,000 (Q4/10D).Document type: Article.
-Grasa E, Seppala J, Alonso A, Haapea M, Isohanni M, Miettunen J, Mendivelso JC, Almazan C, Rubinstein K, Caspi A, Unoka Z, Farkas K, Usall J, Ochoa S, van der Graaf S, Jewell C, Triantafillou A, Stevens M, Reixach E, Berdun J, RESIST MGRP, Corripio I. m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study. Jmir Formative Research. 2023; 7:e46179. DOI:10.2196/46179. PMID:37389933.Document type: Article.
-Groenewold NA, Bas-Hoogendam JM, Amod AR, Laansma MA, Van Velzen LS, Aghajani M, Hilbert K, Oh H, Salas R, Jackowski AP, Pan PM, Salum GA, Blair JR, Blair KS, Hirsch J, Pantazatos SP, Schneier FR, Talati A, Roelofs K, Volman I, Blanco-Hinojo L, Cardoner N, Pujol J, Beesdo-Baum K, Ching CRK, Thomopoulos SI, Jansen A, Kircher T, Krug A, Nenadić I, Stein F, Dannlowski U, Grotegerd D, Lemke H, Meinert S, Winter A, Erb M, Kreifelts B, Gong Q, Lui S, Zhu F, Mwangi B, Soares JC, Wu MJ, Bayram A, Canli M, Tükel R, Westenberg PM, Heeren A, Cremers HR, Hofmann D, Straube T, Doruyter AGG, Lochner C, Peterburs J, Van Tol MJ, Gur RE, Kaczkurkin AN, Larsen B, Satterthwaite TD, Filippi CA, Gold AL, Harrewijn A, Zugman A, Bülow R, Grabe HJ, Völzke H, Wittfeld K, Böhnlein J, Dohm K, Kugel H, Schrammen E, Zwanzger P, Leehr EJ, Sindermann L, Ball TM, Fonzo GA, Paulus MP, Simmons A, Stein MB, Klumpp H, Phan KL, Furmark T, Månsson KNT, Manzouri A, Avery SN, Blackford JU, Clauss JA, Feola B, Harper JC, Sylvester CM, Lueken U, Veltman DJ, Winkler AM, Jahanshad N, Pine DS, Thompson PM, Stein DJ, Van der Wee NJA. Volume of subcortical brain regions in social anxiety disorder: mega-analytic results from 37 samples in the ENIGMA-Anxiety Working Group. Mol Psychiatry. 2023;28(3):1079-1089. doi: 10.1038/s41380-022-01933-9. PMID: 36653677. IF:11,000 (Q1/1D)Document type: Article.
-Gutiérrez F, Aluja A, Rodríguez C, Gárriz M, Peri JM, Gallart S, Calvo N, Ferrer M, Gutiérrez A, Soler J, Pascual JC. Severity in the ICD-11 personality disorder model: Evaluation in a Spanish mixed sample. Frontiers in Psychiatry. 2023; 13:1015489. DOI:10.3389/fpsyt.2022.1015489. PMID:36699492. IF:4,700 (Q2/3D).Document type: Article.
-Joseph Fortuny J, Navarra-Ventura G, Fernández-Gonzalo S, Pousa Tomàs E, Crosas Armengol JM, Palao Vidal D, Jodar Vicente M. Social cognition in first-episode schizophrenia/schizoaffective disorder patients. Span J Psychiatry Ment Health. 2023;16(3):169-174. doi: 10.1016/j.rpsm.2020.04.006. PMID: 32499122.Document type: Article.
-Lin BD, Pinzon J, Blouzard E, van der Horst MZ, Okhuijsen C, van KR, Guloksuz S, Peyrot WJ, Luykx JJ, Genetic Risk Outcome Psychosis GRP, Clozapine Int Consortium CLOZIN IN. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia. JAMA Psychiatry. 2023; 80(2)DOI:10.1001/jamapsychiatry.2022.4234. PMID:36542388. IF:25,800 (Q1/1D).Document type: Article.
-Mateo C, Sanabria JP, Comendador L, Rojas JS, Carmona M, Crespo N, Anyosa F, Selva C, Feliu A, Cardoner N, Deus J, Luciano JV, Mendez JL, Sanz A. Predictive factors of hesitancy to vaccination against SARS-CoV-2 virus in young adults in Spain: Results from the PSY-COVID study. Vaccine: X. 2023; 14:100301. DOI:10.1016/j.jvacx.2023.100301. PMID:37091731.Document type: Article.
-Mezquida G, Amoretti S, Bioque M, García C, Sánchez AM, Pina L, Lopez P, Mané A, Rodriguez R, Corripio I, Sarró S, Ibañez A, Usall J, García MP, Vieta E, Mas S, Cuesta MJ, Parellada M, González A, Berrocoso E, Bernardo M, 2EPs G. Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2023; 16(3)DOI:10.1016/j.rpsm.2023.01.004. PMID:37716849. IF:9,200 (Q1/1D).Document type: Article.
-Navarrete J, Colomer A, Sanabria JP, Luciano JV, Soler J, Garcia J, Demarzo M, Montero J, Bohlmeijer ET, Campos D, Cebolla A, Feliu A. Psychometric properties of the engaged living scale (ELS) Spanish version in a large sample of Spanish pilgrims. Journal of Contextual Behavioral Science. 2023; 28DOI:10.1016/j.jcbs.2023.05.001. IF:5,000 (Q1/2D).Document type: Article.
-Navarrete J, Fontana M, Colomer A, Sanabria JP, Pinazo D, Silvestre A-J, Lau M, Tanay G, García J, Demarzo M, Soler J, Cebolla A, Feliu A, Luciano JV. The Toronto Mindfulness Scale and the State Mindfulness Scale: psychometric properties of the Spanish versions. Frontiers in Psychology. 2023; 14:1212036. DOI:10.3389/fpsyg.2023.1212036. PMID:37484107. IF:3,800 (Q1/3D).Document type: Article.
-Nunez C, Garcia A, Arca G, Agut T, Carreras N, Portella MJ, Stephan C. Breastfeeding duration is associated with larger cortical gray matter volumes in children from the ABCD study. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY. 2023; 64(7)DOI:10.1111/jcpp.13790. PMID:36946606. IF:7,600 (Q1/1D).Document type: Article.
-Oteo Á, García CG, Sánchez AI, Santamaria CA, de Diego J. Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS). OSTEOPOROSIS INTERNATIONAL. 2023; 34(10)DOI:10.1007/s00198-023-06838-z. PMID:37405407. IF:4,000 (Q2/5D).Document type: Review.
-Pascual JC, Arias L, Soler J. Pharmacological Management of Borderline Personality Disorder and Common Comorbidities. CNS DRUGS. 2023; 37(6)DOI:10.1007/s40263-023-01015-6. PMID:37256484. IF:6,000 (Q1/2D).Document type: Article.
-Porta D, Cano M, Navarra G, Serra M, Vicent M, Solé B, Montejo L, Torrent C, Martinez A, Harrison BJ, Palao D, Vieta E, Cardoner N. Disrupted network switching in euthymic bipolar disorder: Working memory and self-referential paradigms. JOURNAL OF AFFECTIVE DISORDERS. 2023; 320DOI:10.1016/j.jad.2022.09.152. PMID:36202301. IF:6,600 (Q1/2D).Document type: Article.
-Portella MJ, González I, Jubero M, Trujols J, Pérez V. Depressive-Like Effects of Foreclosing: A Cross-Sectional Study of Hair Cortisol Concentration. PSYCHOPATHOLOGY. 2023; DOI:10.1159/000530706. PMID:37331349. IF:3,600 (Q2/4D).Document type: Article.
-Sanchez AM, Amoretti S, Enguita M, Mezquida G, Moreno L, Panadero R, Rementeria L, Toll A, Rodriguez R, Roldan A, Pomarol E, Ibanez A, Usall J, Contreras F, Vieta E, Lopez JM, Merchan J, Gonzalez A, Berrocoso E, Bernardo M, Cuesta MJ, 2EPs GRP. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; 67DOI:10.1016/j.euroneuro.2022.11.011. PMID:36495858. IF:5,600 (Q1/2D).Document type: Article.
-Sastre A, Caro I, Ochoa S, Lorente E, Barajas A, Gutiérrez A, Sánchez S, López R, Grasa E, Pousa E, Pélaez T, Cid J, González F, Ruiz I, Baca E, Barrigon ML, Spanish Metacognition Study G. Relationship between cognition and suicidal behavior in recent-onset psychosis. SCHIZOPHRENIA RESEARCH. 2023; 252DOI:10.1016/j.schres.2022.12.042. PMID:36652834. IF:4,500 (Q2/4D).Document type: Article.
-Schmidt C, Briones L, Nicolaou S, Soler J, Pascual JC, Vega D. Non-suicidal self-injury in young adults with and without borderline personality disorder: the role of emotion dysregulation and negative urgency. Anales de Psicologia. 2023; 39(3)DOI:10.6018/analesps.492631. IF:1,700 (Q3/7D).Document type: Article.
-Segal A, Parkes L, Aquino K, Kia SM, Wolfers T, Franke B, Hoogman M, Beckmann CF, Westlye LT, Andreassen OA, Zalesky A, Harrison BJ, Davey CG, Soriano C, Cardoner N, Tiego J, Yücel M, Braganza L, Suo C, Berk M, Cotton S, Bellgrove MA, Marquand AF, Fornito A. Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders. NATURE NEUROSCIENCE. 2023; 26(9)DOI:10.1038/s41593-023-01404-6. PMID:37580620. IF:25,000 (Q1/1D).Document type: Article.
-Segura AG, Mane A, Prohens L, Rodriguez N, Mezquida G, Cuesta MJ, Vieta E, Amoretti S, Lobo A, Gonzalez A, Diaz CM, Bejarano AR, Jimenez E, Baeza I, Legido T, Saiz J, Bernardo M, Mas S, PEPs GRP. Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort. PSYCHIATRY RESEARCH. 2023; 325:115249. DOI:10.1016/j.psychres.2023.115249. PMID:37178502. IF:11,300 (Q1/1D).Document type: Article.
-Segura AG, Mezquida G, Martinez A, Gasso P, Rodriguez N, Moreno L, Amoretti S, Bioque M, Lobo A, Gonzalez A, Garcia A, Roldan A, Vieta E, de la Serna E, Toll A, Cuesta MJ, Mas S, Bernardo M, PEPs GRP. Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode. PSYCHOLOGICAL MEDICINE. 2023; 53(10):PII S0033291722001544. DOI:10.1017/S0033291722001544. PMID:35678455. IF:6,900 (Q1/1D).Document type: Article.
-Segura À-G, Prohens L, Gassó P, Rodríguez N, Garcia C, Moreno L, Andreu Á, Zorrilla I, Mane A, Rodriguez R, Roldán A, Sarró S, Ibáñez Á, Usall J, Sáiz PA, Cuesta MJ, Parellada M, González A, Berrocoso E, Bernardo M, Mas S, Mezquida G, Arbelo N, De Matteis M, Galvañ J, Duque A, Arias i Queralt L, Perez M, Gonzalez I, Toll A, Casanovas F, Sanchez L, Valtueña M, Pomarol E, García MÁ, Butjosa A, Rubio E, Ribeiro M, López JM, Saiz J, León L, Rivero O, Ruiz P, Echevarría RS, García MP. The polygenic basis of relapse after a first episode of schizophrenia. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; 75DOI:10.1016/j.euroneuro.2023.06.003. PMID:37603902. IF:5,600 (Q1/2D).Document type: Article.
-Trujols J, Vicent M, Duran S, Portella MJ. A truly patient-centred evaluation of opioid agonist treatment. The Lancet Psychiatry. 2023; 10(8)DOI:10.1016/S2215-0366(23)00202-X. PMID:37479338. IF:64,300 (Q1/1D).Document type: Letter.
-Valli I, Segura AG, Verdolini N, Garcia C, Berge D, Baeza I, Cuesta MJ, Gonzalez A, Lobo A, Martinez A, Mezquida G, Pina L, Bejarano AR, Mas S, McGuire P, Bernardo M, Vieta E, PEPs GRP. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis. ACTA PSYCHIATRICA SCANDINAVICA. 2023; 148(1)DOI:10.1111/acps.13546. PMID:36912272. IF:6,700 (Q1/2D).Document type: Article.
-Verdolini N, Mezquida G, Valli I, Garcia C, Cuesta M, Vieta E, Bioque M, Lobo A, Gonzalez A, Pina L, Corripio I, Garriga M, Baeza I, Martinez L, Bitanihirwe B, Cannon M, Bernardo M, PEPs GRP. Obstetric complications and clinical presentation in first episode of psychosis. ACTA NEUROPSYCHIATRICA. 2023; :PII S0924270823000091. DOI:10.1017/neu.2023.9. PMID:36861430. IF:3,800 (Q2/5D).Document type: Article.
-Vicent M, Serra M, Navarra G, Trujols J, Balanza V, Portella MJ, Cardoner N. In pursuit of full recovery in major depressive disorder. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2023; 273(5)DOI:10.1007/s00406-022-01487-5. PMID:36085532. IF:4,700 (Q1/3D).Document type: Article.
-Vicent M, Trujols J, Serra M, Navarra G, Puigdemont D, Alemany C, Crivillés S, de Diego J, Cardoner N, Portella MJ. If you feel you can’t, you won’t: the role of subjective and objective cognitive competence on psychosocial functioning in depression. EUROPEAN PSYCHIATRY. 2023; 66(1):e83. DOI:10.1192/j.eurpsy.2023.2454. PMID:37855104. IF:7,800 (Q1/1D).Document type: Article.
(JIF 2022)